Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)

Lemaitre Vascular (LMAT) has disclosed Current Deferred Revenue for 2 consecutive years, with $188000.0 as the latest value for Q2 2019.

Quarterly Current Deferred Revenue fell 80.23% to $188000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $188000.0 through Jun 2019, down 80.23% year-over-year, with the annual reading at $552000.0 for FY2018, N/A changed from the prior year.
Current Deferred Revenue for Q2 2019 was $188000.0 at Lemaitre Vascular, down from $368000.0 in the prior quarter.
The five-year high for Current Deferred Revenue was $951000.0 in Q2 2018, with the low at $188000.0 in Q2 2019.